Le Lézard
Classified in: Health, Business
Subjects: NPT, CHI, SRI

Cure AHC awards $33,000 Grant to Aarhus University (Denmark)


RALEIGH, N.C., Oct. 16, 2017 /PRNewswire/ -- Cure AHC, Inc. has awarded a grant of $33,000 to Karin Lykke-Hartmann, Ph.D., of Aarhus University in Denmark for her project "Neuroelectrophysiological Study of D801Y Mouse Model, Cognition and Learning Focus."  The 4 month project will involve understanding how the plasticity of the neurons contribute towards the cognitive performance in the D801Y mutation of the gene ATP1A3. Findings from this study may be useful for future pharmacological treatments.

"We are hopeful that this project will fill in some key gaps in knowledge about AHC and propel us forward with candidates for treatment," said Dr. Lykke-Hartmann.

"Cure AHC recognizes that cognition/learning poses one of the biggest barriers to those with AHC functioning fully in society. We are hopeful this research will go a long way towards eliminating this symptom of AHC," said Cure AHC Co-Founder and President Jeff Wuchich. Cure AHC plans to fund several other collaborative and complementary research projects in 2017 and 2018, with an aim to raise $600,000 USD.

Alternating Hemiplegia of Childhood (AHC) is a currently incurable, rare and painful neurological disorder that causes episodes of temporary paralysis that last minutes or even days. AHC is often mistaken for cerebral palsy or epilepsy, which impairs the ability to learn and communicate.  AHC also affects muscle control, causing shallow breathing and difficulty walking and swallowing. Researchers discovered the gene that causes Alternating Hemiplegia of Childhood (AHC) in 2012 and they continue to make progress in their understanding of the disease, which aids in better treatment and ultimately a cure for AHC sufferers, as well as potential benefit to more mainstream diseases such as epilepsy, stroke, and heart disease.

Cure AHC is a global 501 (c) 3 Non-profit organization created to raise awareness and research funds to develop a treatment and discover the cure for Alternating Hemiplegia of Childhood. Donations to Cure AHC can be made online through the www.cureahc.org donation page or a check may be sent to Cure AHC, Inc. at 8480 Honeycutt RD, #200 Raleigh, NC 27615. Please visit www.cureahc.org or email [email protected] for more information. To reach Karin Lykke-Hartmann, email Karin at [email protected].

SOURCE Cure AHC


These press releases may also interest you

at 08:07
Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has released a comprehensive contract research organization (CRO) offering tailor-made for sponsors looking to bring diagnostic products...

at 08:05
Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the enrollment of the first patient in a pilot study collecting patient-generated health data (PGHD) during proton radiotherapy for lung cancer in...

at 08:05
Roivant and Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare inflammatory and autoimmune diseases, today announced the successful completion of enrollment in its Phase 2 study evaluating namilumab for...

at 08:05
Revvity, Inc. will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT in Las Vegas, NV. Senior Vice President and Chief Financial Officer Max Krakowiak will provide an update on the Company and its...

at 08:05
Freedom Biosciences, Inc. ("Freedom Bio" or the "Company"), a clinical-stage biotechnology platform focused on developing next-generation neuropsychiatric therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has notified the...

at 08:05
Microbion Corporation today announced that the company won the Advanced Wound Care Summit's Innovation Showcase award. The Innovation Showcase was designed to give presenters, who were picked by a selection committee, an opportunity to demonstrate...



News published on and distributed by: